Britain may restrict heart pump use

Nov 29, 2006

British researchers are urging the restricted use of an implantable pump designed to help heart failure patients while they wait for a transplant.

"Although we believe that the devices have been developed sufficiently to prolong life for some very sick patients who have rapidly deteriorating heart failure, we don't feel they've been developed quite enough yet for widespread use among the whole heart failure population," said lead researcher Linda Sharples of Britain's National Health Service.

Sharples studied health outcomes and the cost effectiveness of the ventricular assist devices for 70 British patients who received the implant between April 2002 and December 2004.

"We compared the VAD group with the very sickest of the transplant candidates and found the healthcare for those individuals was less costly. Those non-VAD patients also had greater survival," Sharples said.

"We recommend that the United Kingdom continue to monitor the development of the new devices," said Sharples. "I think we are all quite hopeful that they will progress and we will have more cost-effective and effective devices in the future."

The review appears in the latest issue of Health Technology Assessment.

Copyright 2006 by United Press International

Explore further: New research demonstrates benefits of national and international device registries

add to favorites email to friend print save as pdf

Related Stories

Philips to buy US medical imaging firm Volcano

Dec 17, 2014

Royal Philips NV said Wednesday it has agreed to acquire U.S. medical equipment maker Volcano Corp. for $1.2 billion (around 1 billion euros) in a deal that would beef up its presence in technology which allows doctors to ...

'Smart' living gets real as connectivity rates rise

Nov 07, 2014

From robots that chop up your vegetables to detectors that measure how long you sleep, such "smart" appliances are becoming more and more a part of daily life, according to industry players.

Recommended for you

New approach to particle therapy dosimetry

Dec 19, 2014

Researchers at the National Physical Laboratory (NPL), in collaboration with EMRP partners, are working towards a universal approach to particle beam therapy dosimetry.

Supplement maker admits lying about ingredients

Dec 17, 2014

Federal prosecutors say the owner and president of a dietary supplement company has admitted his role in the sale of diluted and adulterated dietary ingredients and supplements sold by his company.

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.